Effects of a probiotic add-on treatment on fronto-limbic brain structure, function, and perfusion in depression: Secondary neuroimaging findings of a randomized controlled trial

Gulnara Yamanbaeva, Anna Chiara Schaub, Else Schneider, Nina Schweinfurth, Cedric Kettelhack, Jessica P.K. Doll, Laura Mählmann, Serge Brand, Christoph Beglinger, Stefan Borgwardt, Undine E. Lang, André Schmidt*

*Corresponding author for this work

Abstract

Background: Probiotics are suggested to improve depressive symptoms via the microbiota-gut-brain axis. We have recently shown a beneficial clinical effect of probiotic supplementation in patients with depression. Their underlying neural mechanisms remain unknown. Methods: A multimodal neuroimaging approach including diffusion tensor imaging, resting-state functional MRI, and arterial spin labeling was used to investigate the effects of a four-weeks probiotic supplementation on fronto-limbic brain structure, function, and perfusion and whether these effects were related to symptom changes. Results: Thirty-two patients completed both imaging assessments (18 placebo and 14 probiotics group). Probiotics maintained mean diffusivity in the left uncinate fasciculus, stabilized it in the right uncinate fasciculus, and altered resting-state functional connectivity (rsFC) between limbic structures and the temporal pole to a cluster in the precuneus. Moreover, a cluster in the left superior parietal lobule showed altered rsFC to the subcallosal cortex, the left orbitofrontal cortex, and limbic structures after probiotics. In the probiotics group, structural and functional changes were partly related to decreases in depressive symptoms. Limitations: This study has a rather small sample size. An additional follow-up MRI session would be interesting for seeing clearer changes in the relevant brain regions as clinical effects were strongest in the follow-up. Conclusion: Probiotic supplementation is suggested to prevent neuronal degeneration along the uncinate fasciculus and alter fronto-limbic rsFC, effects that are partly related to the improvement of depressive symptoms. Elucidating the neural mechanisms underlying probiotics' clinical effects on depression provide potential targets for the development of more precise probiotic treatments.

Original languageEnglish
JournalJournal of Affective Disorders
Volume324
Pages (from-to)529-538
Number of pages10
ISSN0165-0327
DOIs
Publication statusPublished - 01.03.2023

Funding

The study was supported by the Gertrud Thalmann Foundation of the University Psychiatric Clinics (UPK) Basel (SBo, UEL), the Kämpf-Bötschi Foundation (UEL), the research fund junior researchers from University of Basel (Appln 3MS1041, AS), the research fund of the UPK Basel (AS) and the Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung sowie der medizinischen Bildauswertung (AS). MENDES S.A., Switzerland, supplied the investigational medicinal product. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The study was supported by the Gertrud Thalmann Foundation of the University Psychiatric Clinics (UPK) Basel (SBo, UEL), the Kämpf-Bötschi Foundation (UEL), the research fund junior researchers from University of Basel (Appln 3MS1041, AS), the research fund of the UPK Basel (AS) and the Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung sowie der medizinischen Bildauswertung (AS). MENDES S.A. Switzerland, supplied the investigational medicinal product. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. AS had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. LM, CB, SBo, AS, and UEL designed the study. GY, ACS, ES, NS, CK, JPKD, and AS contributed to the acquisition, analysis, or interpretation of data. Statistical analyses were performed by GY and ACS. Administrative, technical, or material support was provided by LM, SBr, SBo, AS, and UEL. GY, ACS, and AS drafted the manuscript. All authors critically reviewed the article and approved the final manuscript. T1-weighted structural MRI data of 50 patients at baseline were recently published in the paper “Neural mapping of anhedonia across psychiatric diagnoses: A transdiagnostic neuroimaging analysis” (Schaub et al. 2021). The authors report no biomedical financial interests or potential conflicts of interest.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

DFG Research Classification Scheme

  • 2.23-04 Cognitive, Systems and Behavioural Neurobiology
  • 2.23-08 Human Cognitive and Systems Neuroscience
  • 2.23-09 Biological Psychiatry

Fingerprint

Dive into the research topics of 'Effects of a probiotic add-on treatment on fronto-limbic brain structure, function, and perfusion in depression: Secondary neuroimaging findings of a randomized controlled trial'. Together they form a unique fingerprint.

Cite this